Name: UMIN ID:
Unique ID issued by UMIN | UMIN000023763 |
---|---|
Receipt number | R000018461 |
Scientific Title | The Phase II study on the efficacy and safety of weekly nab-paclitaxel with 3 rd line therapy or more of advanced or recurrent non-small cell lung cancer after disease progression on 2nd line therapy or more |
Date of disclosure of the study information | 2016/08/25 |
Last modified on | 2016/08/25 16:11:13 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/08/25 16:12:12 |